Judith Abrams

Medicine · Health Sciences

39h-index6.3kcitations168works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(11), Multiple Myeloma Research and Treatments(11), Immunotherapy and Immune Responses(9), Monoclonal and Polyclonal Antibodies Research(9), Cancer Treatment and Pharmacology(9)

Publications164 total

Supplementary Table from Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors
2025Open Access
Data from Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors
2025Open Access
Supplementary Table from Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors
2025Open Access
The NEON (Nerve rEpair Or Not) trial: a randomized controlled trial of microsurgical repair <i>versus</i> nerve alignment for digital nerve injury
British journal of surgery·2025Open Access
Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem
Journal of Medical Internet Research·2025· 1 citedOpen Access
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
The Lancet Infectious Diseases·2025· 4 citedOpen Access
Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem (Preprint)
2024
Accelerating healthcare innovation: the role of Artificial intelligence and digital health technologies in critical path institute’s public‐private partnerships
Clinical and Translational Science·2024· 5 citedOpen Access
PRAME immunohistochemistry compared to traditional FISH testing in spitzoid neoplasms and other difficult to diagnose melanocytic neoplasms
Frontiers in Medicine·2023· 5 citedOpen Access
The impact of high intensity interval training in a diverse group of cancer survivors: CAPABLE, a pilot study
Preventive Medicine Reports·2023· 2 citedOpen Access
Supplementary Tables 1-2 from Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
2023Open Access
Supplementary Tables 1-4 from Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays
2023Open Access
Data from A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
2023Open Access
Data from Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays
2023Open Access
Supplementary Figure Legend from A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
2023Open Access
Supplementary Figure 1 from A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
2023Open Access
Data from Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
2023Open Access
Supplementary Tables 1-2 from A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
2023Open Access
Supplementary Tables 1-4 from Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays
2023Open Access
Data from A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Michael A. Tainsky(7), Fazlul H. Sarkar(6), Ann G. Schwartz(6), Mustafa Abbas(5), Sadia Abbasi(5), Alfie Abbott(5), Ashraf Omar Abdelaziz(5), Mohamed A. O. Abdelfattah(5), Basir Abdul(5), Althaf Abdul Rasheed(5), Rezan A. Kadir(5), Abdulfatahi Abdulmumeen(5), Niyaz Abdulshukkoor(5), Kula Abdusamad(5), Yazeed Abed El Khaleq(5), Mai Abedalla(5), Adebanke Aboaba(5), Hani Abo-Leyah(5), Ahmed Abou-Haggar(5), Mahmoud Abouibrahim(5)